HMGCoA REDUCTASE INHIBITOR-ANGIOTENSIN CONVERTING ENZYME INHIBITOR COMPOUNDS
A compound that contains at least two independently active pharmacological moieties, either covalently conjoined through a physiologically labile linker or ionically associated. One pharmacological moiety is an HMGCoA reductase inhibitor (such as a statin). Another pharmacological moiety is an angio...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | A compound that contains at least two independently active pharmacological moieties, either covalently conjoined through a physiologically labile linker or ionically associated. One pharmacological moiety is an HMGCoA reductase inhibitor (such as a statin). Another pharmacological moiety is an angiotensin converting enzyme inhibitor.
L'invention concerne un composé contenant au moins deux fractions pharmacologiques indépendamment actives, soit liées de manière covalente via un liant physiologiquement labile soit ioniquement associées. Une fraction pharmacologiquement active est un inhibiteur de la HMGCoA réductase (tel qu'une statine). L'autre fraction pharmacologiquement est un inhibiteur de l'enzyme de conversion de l'angiotensine. |
|---|